Claudia Asperti
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Impact of asthma on severe food-induced allergic reactions: a systematic review and meta-analysis.
Journal: European annals of allergy and clinical immunology
Published: June 26, 2024
Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated in vitro and in vivo.
Journal: Molecular therapy. Methods & clinical development
Published: May 25, 2023
Unbiased assessment of genome integrity and purging of adverse outcomes at the target locus upon editing of CD4+ T-cells for the treatment of Hyper IgM1.
Journal: The EMBO journal
Published: April 04, 2023
The role of skin tests with polyethylene glycol and polysorbate 80 in the vaccination campaign for COVID-19: results from an Italian multicenter survey.
Journal: European annals of allergy and clinical immunology
Published: March 17, 2023
Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells.
Journal: Blood
Published: December 05, 2022
Characterization and Functional Analysis of CD44v6.CAR T Cells Endowed with a New Low-Affinity Nerve Growth Factor Receptor-Based Spacer.
Journal: Human gene therapy
Published: February 08, 2021
CAR T Cells Redirected to CD44v6 Control Tumor Growth in Lung and Ovary Adenocarcinoma Bearing Mice.
CAR T Cells Redirected to CD44v6 Control Tumor Growth in Lung and Ovary Adenocarcinoma Bearing Mice.
Journal: Frontiers in immunology
Published: September 11, 2019
Mechanism of Action of the Tumor Vessel Targeting Agent NGR-hTNF: Role of Both NGR Peptide and hTNF in Cell Binding and Signaling.
Journal: International journal of molecular sciences
Published: July 31, 2019
Codon Optimization Leads to Functional Impairment of RD114-TR Envelope Glycoprotein.
Journal: Molecular therapy. Methods & clinical development
Published: November 29, 2016
The tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanisms.
Journal: Oncoimmunology
Published: February 03, 2015
Molecular dynamics reveal that isoDGR-containing cyclopeptides are true αvβ3 antagonists unable to promote integrin allostery and activation.
Journal: Angewandte Chemie (International ed. in English)
Published: March 14, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026